Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Age Range: 40-80 Gender: All Study Description: The TemPo studies are evaluating the efficacy and safety of an investigational drug for Parkinson’s Disease. If you are interested in participating, you will be asked to attend a screening visit to determine your eligibility to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo to be taken once daily for 6 months, alongside your current medication (if any). Following the Study Treatment Period, you will have the option to participate in an Open-label Extension Study where you are guaranteed to receive the active study drug. Total study duration, (not including the Open Label Extension Period), is approximately 27 weeks with 12 office visits. The doctor’s office conducting the study will be able to provide you with more information about the study requirements Participants who qualify for the study will receive the study drug, study-related consultation and care, study visits tests, assessments and procedures at no cost, and may be compensated for their time and travel expenses. Qualifications: - Must be diagnosed with Parkinson’s Disease LESS than 3 years ago - Symptoms have gotten worse since diagnosis - Cannot have previously undergone a surgical procedure for Parkinson's Disease (example: deep brain stimulation) - Cannot have a history of brain tumor, epilepsy, or seizures - In the past year, have you had any hallucinations or episodes of psychosis for which you had to consult with a psychiatrist? (answer NO) - Cannot have had a heart attack in the past year - No cancer in last 5 years

SmartAdv